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Abstract
BACKGROUND: Dental gels have several advantages over other oral dosage forms. Being a viscoplastic dosage 
form, the gel, when applied to the damaged area of the gum or mucous membrane, creates a protective film, 
preventing mechanical irritation, and providing a localized effect of the drug components.
AIM: The aim of this work was to develop the composition and technology of the dental gel of meloxicam, the study 
of the main technological and consumer characteristics, as well as the local irritating effect of the dosage form.
METHODS: Dental gels were prepared using purified water, alcohol, glycerol, and buckthorn oil as solvents, 
gelling agents used were: Hydroxyethylcellulose Natrosol® 250 HHX Pharm, Carbopol® 974P NF Polymer, and 
solubilizer Poloxamer 407 (Lutrol® F 127). The bioadhesive component and Noveon® Polycarbophil component 
were used for dental gel preparation. Aspartame was used as sweetener. Menthol and ascorbic acid were used 
to correct the organoleptic properties of the pharmaceutical composition. The formulated dental gel of meloxicam 
at a concentration of 7.5% was evaluated for organoleptic properties, pH, rheological characteristics, bioadhesive 
properties, and stability under the accelerated aging period. The in vivo local irritant effect was evaluated using ten 
rabbits by cutaneous, subcutaneous, subconjunctival administration, as well as application to the upper palate.
RESULTS: Based on the results of studying technological and organoleptic properties, the optimal composition 
based on the Natrosol® 250 HHX hydroxyethylcellulose gelling agent, glycerol solvent, and purified water in the ratio 
1/5 was selected, the composition contains Noveon® bioadhesive in an amount of 2%. The composition has good 
taste, pH close to pH of saliva has high bioadhesive properties, satisfactory rheological characteristics. The shelf 
life of the experimental series by accelerated aging was 2 years. The selected composition does not have a local 
irritant effect.
CONCLUSION: A new dosage form of meloxicam was developed – a gel for use in dental practice.
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Introduction
According to the WHO statistics, 98% of people 
in the world have a history of inflammatory diseases 
of the oral cavity, most of which are inflammatory 
periodontal diseases resulting in tooth loss with the 
absence of surgical intervention, as well as leading to 
morphofunctional changes in the masticatory apparatus, 
which are accompanied by a pain syndrome affecting 
the psychoemotional sphere patient activity, reduce 
resistance to the action of infectious and viral agents, 
increase the sensitization of the body, resulting in a 
decrease in the overall quality of life of the patient [1], [2].
In dental practice, the most common 
pharmacological group for relieving pain, as well 
as the part of complex therapy, is nonsteroidal anti-
inflammatory drugs (NSAIDs) [3]. The great popularity 
of NSAIDs is due to the fact that they have anti-
inflammatory, analgesic and antipyretic effects, affect 
the symptoms observed in a wide range of diseases. 
According to the FDA, the proportion of dosage forms 
used in dentistry based on NSAIDs is as follows: 
Solutions (~60%), aerosols (~25%), pastes (~8%), and 
gels (~7%). Thus, there is no extensive nomenclature 
of dental gels, although they have several advantages, 
specifically, they have a point effect on the site of 
inflammation, the absence of systemic effects due to 
the small mucosal coating area, as well as ease of use.
Meloxicam – carboxamide with the primary 
inhibitory activity of COX-2 was chosen as the object 
of study. In vitro studies with human tissues confirmed 
a high affinity of meloxicam with COX-2, while COX-1 
inhibited only at the highest concentrations (ratio of 
50% inhibitory concentration to COX-2: COX-1 = 0.09 
in whole blood tests). Meloxicam has a bioavailability 
of 89% after oral administration, is strongly associated 
with plasma proteins, and its half-life is 20–24 h. It easily 
penetrates into the synovial fluid, reaching 45–57% of 
plasma concentrations [4], [5].
At present, in the development of drugs, there 
is a tendency to search for new potent molecules, 
often targeting lipophilic receptors, which in general 
leads to an increase in the number of highly lipophilic 
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drugs with a limited therapeutic window (a low dose 
can be ineffective, and while a high dose leads to 
toxicity) [6], [7], [8], as a result of this, it was decided to 
use meloxicam as a weakly lipophilic drug with proven 
effectiveness and known toxicity.
The purpose of this study was to create a new 
dosage form of NSAIDs for use in dental practice, a 
comprehensive assessment of its physicochemical and 
biopharmaceutical characterization
Materials and Methods
Materials
The object of the study was the drug substance 
of meloxicam Boehringer Ingelheim (USP 39, Ph. 
Eur. 10); as solvents, the purified water (USP 39, Ph. 
Eur. 10), alcohol 96% (USP 39, Ph. Eur. 10), glycerin 
(USP 39, Ph. Eur. 10), and buckthorn oil (SPH RF XI) 
were used. Other excipients used were Poloxamer 407 
Lutrol® F 127, BASF (USP 39, Ph. Eur. 10), Carbopol® 
974P NF Polymer, Lubrizol (USP 39, Ph. Eur. 10), 
hydroxyethylcellulose Natrosol® 250 HHX Pharm, 
Ashland (USP 39, Ph. Eur. 10), Noveon® Polycarbophil, 
Ashland, menthol (USP 39, Ph. Eur. 10), ascorbic acid 
(USP 39, Ph. Eur. 10), and aspartame (USP 39, Ph. 
Eur. 10).
According to the published data, the 
concentration of NSAIDs in the developed dosage 
form was chosen, which amounted to 7.5% [5]. This 
concentration was calculated based on the average 
daily doses of meloxicam at the rate of 0.5 ml of gel 
per dose.
First, a suspension of the active pharmaceutical 
ingredient was made by dispersing meloxicam in 
water. Gel-forming agent samples were obtained 
by conventional methods [9]. A gel-forming agent, 
flavorings, and a mucoadhesive agent were added to 
the resulting dispersion with continuous stirring using 
the ECROS ES 6120 magnetic stirrer (Russia) at a 
temperature of 20±2°C. The resulting composition was 
left for structuring for 1.5 h. At the end of the process, 
standardization was performed.
Methods
Organoleptic properties
Two methods of organoleptic evaluation were 
used to determine the taste of experimental samples. 
To determine the taste characteristics of dispersions of 
NSAIDs in various solvents introduced into the model 
gel base, the organoleptic method of taste assessment 
according to A.I. Tentsova. A group of twenty volunteers 
assesses the taste of gel samples according to the 
proposed scheme. The following indicators are taken 
into account: “Sweetness” (1 – unsweetened, and 5 – 
very sweet), “presence of aftertaste” (1 – absent, and 5 – 
strong present), “character of aftertaste” (1 – unpleasant, 
and 5 – very pleasant), and “taste in general” (1 – 
unpleasant, and 5 – pleasant) [10]. To characterize the 
tastes of the experimental compositions after the initial 
taste correction and assess the influence of the solvent 
on the organoleptic properties of the finished dosage 
form, the profile method was used. This method is based 
on the construction of profilograms based on the results 
of assessing the taste of the compositions on a five-point 
scale according to indicators characterizing the taste of 
the compositions (acidic/bitter/sweet), the taste of the 
gelling agent. In addition, there is taking into account 
the texture indicator (numerical indices: 1 – the sign is 
absent; 2 – the sign is weakly expressed; 3 – a sign of 
normal intensity; and 4 – a sign is very pronounced) [10].
Evaluation of pH
When developing a dosage form for dental 
use, it is necessary to determine its pH, since a low 
pH value (pH 3–4) contributes to the demineralization 
of enamel [11]. To determine the pH, an aqueous 
extraction of the gel sample under study was prepared, 
the resulting extraction was dispersed on an ECROS 
ES 6120 magnetic stirrer (Russia) for 15 min at room 
temperature, and the pH was determined on an Aquilon 
pH-410 pH meter (Russia).
Rheological properties
A rheological study of the obtained samples 
was carried out on a coaxial rotational viscometer 
Lamy Rheology RM 200 (France) using the «cylinder-
in-cylinder» geometry MS-DIN 33. The results obtained 
were approximated with the Casson model [12], 
recommended for pharmaceutical compositions in 
the form of gels, using the Rheomatic software. To 
conduct the experiment, the samples are tested one by 
one on a viscometer at a temperature of 20°C, which 
is the average temperature for storing the gel; and at 
a temperature of 37°C, which is temperature of the 
intended application site. The plastic viscosity of the 
samples was studied in the range of shear rates from 
0 to 300 s−1.
Evaluation of bioadhesive properties
Bioadhesion for oral dosage forms for the local 
use is one of the most important indicators because 
it determines the dose retention time on the mucous 
membrane, the completeness of absorption of the active 
substance, and the onset of the therapeutic effect.
In the experiment to determine the separation 
force, a lever mechanism was used, on the left shoulder of 
which there were movable (upper) and fixed (lower) parts, 
on the right – a place for cargo placement. Previously, 
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non-woven material of the spanbond type was attached 
to the lower and upper part of the lever mechanism. 
A 20% mucin solution was applied to the lower part, and 
a test gel sample was applied to the upper part. In this 
case, the mucin layer thickness was controlled, which 
was 0.1 mm, which lies within the range of the mucus 
layer thickness under physiological conditions. A load was 
placed on the platform and the weight was recorded at 
which the upper plate was completely detached from the 
lower one. Bioadhesion was determined at a temperature 
of 20 ± 0.5°C, which is the storage temperature of the 
tested gels. The amount of adhesion was calculated as 
the product of the mass of sand and the acceleration of 
gravity (g = 9.81 m/s2) and was expressed in newtons.
A modified model proposed by Puratchikody 
et al. [13] was used to determine in vitro retention 
times. A spanbond section (SPANLAB, Russia) with 
an area of 676 mm2 was attached to a glass plate 
measuring 260 × 760 mm, onto which a 4% aqueous 
solution of type II porcine stomach mucin was applied 
(SIGMA, Sigma-Aldrich, USA, Cat. No. M 2378). On a 
disk made of spunbond, 26 mm in diameter, soaked in 
potassium phosphate buffer solution (pH 6.8), 1.0 g of 
the test sample was applied and uniformly distributed 
over the disk area. Treated spunbond membranes 
were combined with each other, thereby combining 
into a model system. Next, the resulting system was 
placed in the cell of the pharmacopeia apparatus of the 
disintegration tester of solid dosage forms ERWEKA 
ZT 220 “Swinging basket.” The dissolution medium 
was potassium phosphate buffer (pH 6.8); the medium 
temperature was 37°C. During the experiment, the time 
was noted after which the polymer disk with the test 
drug was torn off from the mucin-soaked spunbond.
Aggregate stability
The aggregate stability of the gel samples was 
assessed visually by the absence of visible changes 
(separation, sedimentation, and heterogeneity) and by 
the kinetic stability coefficient (Kk) after centrifugation 
for 5 min at a speed of 3000 rpm on a Biosan LMC-
3000 centrifuge (Germany) 5 ml of sample gels in 
centrifuge tubes Greiner Bio-One 15 ml. The kinetic 
stability coefficient was calculated by the formula:
1
2
=K
ÍK
Í ,
where
H1 – is the height of the layer of the precipitated 
phase;
H2 – is the height of the gel layer.
The indicator was determined in experimental 
samples during storage under natural conditions 
(temperature 20 ± 2°C, and humidity 55%).
The method of “accelerated aging” determined 
the shelf life of the developed dosage form. According 
to RSF XIV (Russia State Pharmacopoeia XIV), 
the limiting temperature of experimental storage 
was chosen + 40°С; the thermostat Binder ED 115 
(Germany) was used.
Local irritant effect
The local irritating effect was determined by 
the methods of cutaneous, subcutaneous, conjunctival 
tests, and on the oral mucosa in chinchilla rabbits 
weighing 3.6–4.1 kg in accordance with the “Guidelines 
for the Preclinical Studies of Medicines” [14]. The 
care and maintenance of animals were carried 
out in accordance with the recommendations and 
requirements of Directive 2010/63/EU of the European 
Parliament and of the EU Council of September 22, 
2010, on the protection of animals used for scientific 
purposes. All animal experiments were approved by the 
Sechenov University Ethics Committee.
Assessment of the local irritant effect on the 
skin was carried out on ten rabbits. Two days before 
the experiment, sections of 5 × 5 cm in size were 
trimmed on the back on symmetrical sections of the 
back on either sides of the spine, leaving a 2 cm hairline 
between them. The right side of the animal serves to 
apply the studied drug, the left to control. The exposure 
time is 4 h. Exposure is repeated every day for 7 days. 
The skin condition is recorded visually daily. Functional 
morphological disorders of the skin are noted in points 
(erythema, edema, cracks, necrosis, peeling, dryness, 
and ulceration). After the experiment, animals were 
monitored for 14 days. The test drug was added 0.5 ml 
per clipped area on the right side of the rabbit. The 
same amount of distilled water was applied to the left 
side.
Subcutaneous tests were conducted on ten 
rabbits. Injections were administered with 0.1 ml of gel 
once in shaved areas of the skin of the animal. The state 
of injections was noted immediately, 24, 48, and 72 h 
after administration. The degree of tissue reaction was 
evaluated, including erythema and edema. After the 
experiment, animals were also monitored for another 
14 days.
The local irritant effect on the eyes was 
evaluated on ten rabbits. The gel in an amount of 
0.1 ml was instilled 3 times a day for 7 days. One eye 
is used to apply the product, the other as a control; 
0.1 ml of purified water was injected into it. The severity 
of hyperemia, conjunctival edema, vascular injection 
of the sclera, the condition of the cornea and iris, and 
the number and quality of discharge from the eye for 
14 days, which were evaluated in points, were noted.
In addition, the local irritating effect of the gel on 
the mucous membrane of the oral cavity was evaluated. 
For this, 0.1 ml of gel was applied to the palate of 10 
rabbits 3 times a day for 7 days. To the control rabbits 
in the amount of ten pieces to the palate, the purified 
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water was applied. The condition of the mucosa was 
recorded visually daily. Functional morphological 
disorders of the mucosa were noted in points (erythema, 
edema, fissures, necrosis, hyperemia, dryness, and 
expressions). After the experiment, animals were 
monitored for 14 days.
Results and Discussion
The experimental substantiation of the solvent 
is one of the most important steps in the development 
of a suitable gel formulation for local oral drug delivery. 
Meloxicam is practically insoluble (more than 10,000 g/
ml) in oral solvents and has a sharp taste, which may 
limit its use in dental practice.
Therefore, it was introduced into the following 
solvents as a suspension:water, ethanol, glycerol, and 
buckthorn oil in the range of ratios 1:5, 1:10, 1:20, 1:30, 
and 1:40. Stable for 7 days dispersions were obtained 
in glycerol in a ratio of 1:40 and in oil in a ratio of 1:10. 
To obtain a sedimentation-stable suspension in ethanol 
the need for the introduction of a solubilizer was 
identified, which was used as Poloxamer 407 Lutrol® 
F 127 in the concentration range from 5% to 15%. It 
was shown that a stable dispersion is formed when a 
solubilizer is added at a concentration of 15%.
Based on the aggregate stable dispersions, 
experimental samples of dental gels were obtained, 
the composition of which is presented in Table 1. 
The most common and widely used gelling agents 
hydroxyethylcellulose Natrosol 250 HHX (Ashland) and 
Carbopol® 974P (Lubrizol) were obtained.
Dental gels must have significant bioadhesion 
to ensure their therapeutic effect; therefore, Noveon® 
Polycarbophil (Ashland) was additionally added to 
formulations 5, 6, and 8.
The next step was the determination of the 
organoleptic properties of the experimental gel samples, 
but to study the influence of solvents, solubilizer, and 
bioadhesive on taste, all gels were obtained on one 
gellant – Carbopol® 974P. To determine the taste used 
organoleptic method for assessing taste, according to 
A.I. Tentsova. The taste index was derived from the 
obtained results as the arithmetic mean of the obtained 
numerical estimates given by volunteers. A higher 
numerical index indicates a better masking potential of 
the composition. The results are shown in Table 2.
Thus, based on the taste assessment of 
the experimental compositions, it was found that 
compositions 2 and 4 require adjustments to the 
organoleptic properties – due to the fact that they 
include excipients that are not indifferent in taste and 
smell – the Poloxamer 407 solubilizer and ethanol as 
a solvent. To correct the taste, the synthetic sweetener 
aspartame was used at a concentration of 0.1%, the 
acidity regulator ascorbic acid at a concentration of 
0.05% and the odor flavor menthol at a concentration 
of 0.1% – the choice of concentrations was also carried 
out according to the organoleptic method A.I. Tentsovа.
To characterize the tastes of the experimental 
compositions after conducting taste correction and 
assessing the effect of the gel on the organoleptic 
properties of the finished dosage form, the profile 
method was used. This method was rested on the 
construction of profilograms based on the results 
of assessing the taste of the compositions on a five-
point scale according to indicators characterizing 
the taste of the compositions (acidic/bitter/sweet). In 
addition, the taste of the gelling agent and the indicator 
of texture were taking into account using numerical 
indices (1 – the sign is absent; 2 – the sign is weakly 
expressed; 3 – the sign of normal intensity; and 4 – sign 
is expressed very strongly) [10]. Profilograms of taste 
are presented in Figure 1.
All samples analyzed after adjusting the taste 
had satisfactory organoleptic characteristics. At the 
Table 1: The compositions of the experimental samples of meloxicam gels
Ingredients Number of composition
Amount of ingredients, %
1 2 3 4 5 6 7 8 9 10
Meloxicam 7.50 7.50 7.50 7.50 7.50 7.50 7.50 7.50 7.50 7.50
Ethanol 20.00 20.00 - - - - - - - 20.00
Purified water 57.50 71.70 80.20 76.75 76.75 76.75 69.00 74.75 83.60 69.25
Poloxamer 15.00 - - - - - - - - -
Carbopol - 0.75 - 0.75 0.75 0.75 - - 0.75 -
Buckthorn oil - - 7.50 - - - - - 8.20 -
Hydroxyethylcellulose - - 4.50 - - - 4.00 4.00 - 3.00
Glycerol - - - 15.00 15.00 15.00 19.60 15.00 - -
Bioadhesive - - - - 1.00 2.00 - 2.00 - -
Figure 1: Profilograms of the taste of meloxicam gel samples
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same time, a specific taste of the gel base was also 
noted in some formulations. This is more relevant for 
composition 4, which has a pronounced texture and a 
slightly bitter aftertaste. Compositions 2, 7, and 8 have a 
characteristic smack of a gel-forming agent of moderate 
intensity. According to the data obtained in the course 
of complex studies of the organoleptic properties of the 
compositions by the organoleptic method A.I. Tentsova 
and profile method, the most acceptable organoleptic 
characteristics are compounds 2, 7, and 8.
The most important indicator in the development 
of gels is their aggregative stability. A measure of 
stability was the kinetic stability coefficient calculated 
as the ratio of the separated phases after centrifugation 
of the sample. It was accepted that the samples are 
stable with a kinetic stability coefficient not exceeding 
0.1 (Table 3).
Compositions with buckthorn oil began to 
exfoliate after a week of storage. Samples using ethanol 
as a solvent also did not show high stability. Samples 
2, 4, 5, 7, and 8 had satisfactory stability, since their 
kinetic stability coefficient did not exceed 0.1. They also 
did not observe delamination, turbidity, discoloration, 
or gel consistency; there was no separation of the 
dispersion medium from the polymer network formed 
by the molecules of the dispersed phase (there was no 
syneresis).
At the next stage of the study, the 
physicochemical characteristics of stable meloxicam 
gel samples were evaluated.
According to the data obtained, it can be 
concluded that samples 7 and 8 have the most 
satisfactory pH values since their pH is as close as 
possible to the saliva pH (6.4–7.2) [15], which will not 
contribute to the destruction and demineralization of 
long-term use enamels [16]. However, the remaining 
samples satisfy the pharmacopeial requirements for 
this indicator.
Table 2: The results of determining the taste of meloxicam gel 
samples by A.I. Tentsova
Indicator Number of composition
1 2 3 4 5 6 7 8 9 10
Sweetness 2.0 2.0 1.0 1.0 1.0 2.0 4.0 4.0 3.0 4.0
The presence of aftertaste 5.0 5.0 1.0 4.0 4.0 4.0 2.0 2.0 3.0 5.0
Aftertaste character 2.0 3.0 5.0 5.0 5.0 5.0 4.0 4.0 5.0 4.0
Taste in general 1.0 2.0 5.0 5.0 5.0 4.0 4.0 5.0 5.0 4.0
When studying the rheological characteristics 
of the experimental samples, it was shown that 
Table 3: Kinetic stability coefficients of meloxicam gel 
samples
Sample No. Shelf life, days
1 7 30 60 90
Кк
1 0.10 0.15 0.18 0.25 0.32
2 0.00 0.00 0.00 0.00 0.09
3 0.00 0.35 0.38 0.40 0.41
4 0.00 0.00 0.08 0.09 0.10
5 0.00 0.00 0.09 0.10 0.10
6 0.00 0.00 0.12 0.14 0.26
7 0.00 0.00 0.00 0.00 0.00
8 0.00 0.00 0.00 0.00 0.00
9 0.00 0.12 0.15 0.29 0.35
10 0.00 0.00 0.08 0.12 0.28
when using ethanol as a solvent of meloxicam, 
the yield strength characterizing the strength of the gel 
structure and plastic viscosity significantly differ from 
the performance of the samples, in which glycerol 
was used in various concentrations (Table 4). Thus, 
the introduction of ethanol in the pharmaceutical 
composition cannot ensure its stability during storage 
under shear stress (e.g., by extrusion from a tube by a 
patient). The rheological characteristics of the studied 
formulations 4, 5, 7, and 8 lie in the optimum range for 
dental gels defined by author [12].
Then, the bioadhesive properties of meloxicam 
gel samples were studied using two methods: The “peel” 
method, where the greater the peel force, the higher 
bioadhesion, and the “swinging basket” method, in which 
the longer the retention time, the higher bioadhesion.
According to Table 5, compositions 4 and 5 
based on Carbopol® 974P have significantly lower 
bioadhesive retention properties than formulations 7 
and 8 based on Natrosol® 250 HHX. The adhesion 
values of compositions 4 and 5 are 1.7 ± 0.164 s and 
2.0 ± 0.11 s, and for compositions 7 and 8 more than 
30 times higher: 65.0 ± 0.084 s and 77.0 ± 0.071 s, 
respectively. In addition, a noticeable effect on the bio-
adhesion of Noveon® Polycarbophil administration 
(compositions 5 and 8). The adhesion value of 
composition 5 is higher by 5.6 N and the retention time 
is 0.3 s than that of composition 4. For composition 8, 
the adhesion value is higher by 1.2 N and the retention 
time by 12 s. Thus, compositions 7 and 8 have the best 
bio-adhesive properties.
To determine the shelf life by the method 
of “accelerated aging,” three series of samples of 
composition 7 and 8 were made as the most satisfactory 
for all previously studied indicators. For each series, 
the following quality indicators were evaluated during 
storage: Description, authenticity and quantification by 
HPLC, viscosity, particle size, pH, and microbiological 
purity.
Table 4: Physicochemical characteristics of meloxicam gel 
samples
Sample 
No.
Indicator
pH ± SD Casson yield strength, Pa ± SD Casson plastic viscosity, Pa.s ± SD
at t 37°С at t 20°С at t 37°С at t 20°С
Sample 2 5.13 ± 0.007 10.6 ± 0.084 12.3 ± 0.084 0.208 ± 0.001 0.215 ± 0.001
Sample 4 5.37 ± 0.008 110.7 ± 0.084 112.5 ± 0.084 0.320 ± 0.001 0.321 ± 0.001
Sample 5 5.45 ± 0.009 100.5 ± 0.071 102.4 ± 0.071 0.298 ± 0.001 0.311 ± 0.001
Sample 7 6.54 ± 0.008 145.3 ± 0.084 148.9 ± 0.084 0.477 ± 0.001 0.487 ± 0.001
Sample 8 6.55 ± 0.008 148.6 ± 0.071 156.8 ± 0.071 0.485 ± 0.001 0.495 ± 0.001
The shelf life of sample 7 was 1.5 years 
and the shelf life of sample 8 was 2 years, so it was 
considered more promising for further development. In 
addition, bioadhesive characteristics are also higher for 
composition 8.
Table 5: The results of the study of bioadhesion in samples of 
meloxicam gels
Sample No. The amount of adhesion, N ± SD Retention time, sec ± SD
Composition 4 26.095 ± 0.004 1.7 ± 0.164
Composition 5 31.713 ± 0.002 2.0 ± 0.11
Composition 7 29.442 ± 0.002 65.0 ± 0.084
Composition 8 30.682 ± 0.002 77.0 ± 0.071
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For drugs applied to the mucous membrane, 
the absence of a local irritant effect is extremely 
important. For sample 8, the local irritant effect was 
evaluated in several ways.
When determining and evaluating the local 
irritating effect on the skin, the degree of erythema and 
edema was 0, which corresponds to the absence of a 
local irritating effect. With intradermal administration of 
a dental gel with meloxicam, the degree of intradermal 
reactions immediately after administration is 6 points 
out of 8. After 72 h, the degree decreases to 0, which 
corresponds to the absence of a local irritant effect. 
In the gel study to determine and evaluate the local 
irritant effect on the eyes, the degree of local irritant 
effect corresponds to “weak or absent.” When this 
composition was applied to the mucous membrane 
of the oral cavity, a slight edema (0 or 1 point) or its 
absence, slight redness, or its absence (0 or 1 point) 
was observed, which also corresponds to the absence 
of a local irritant effect. Thus, a gel with meloxicam does 
not have a local irritant effect.
Conclusions
The meloxicam dental gel composition 8 
was developed based on the Natrosol® 250 HHX 
hydroxyethylcellulose gelling agent, glycerol solvent 
and purified water in a ratio of 1/5 and 2% Noveon® 
Polycarbophil bioadhesive was present in the 
composition. The composition has good taste, a pH 
close to the pH of saliva, high bioadhesive properties, 
and satisfactory rheological characteristics. The shelf 
life of the experimental series by accelerated aging 
was 2 years. The selected composition does not have 
a local irritant effect.
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